Effect of purified 31K bovine inhibin on the specific binding of gonadotropin-releasing hormone to rat anterior pituitary cells in culture.
The mechanism by which inhibin decreases the responsiveness of the pituitary gonadotroph to GnRH in terms of secretion of gonadotropins is largely unknown. We studied the effect of pure 31K bovine inhibin on the specific binding of GnRH to rat anterior pituitary cells in culture using iodinated Buserelin as tracer. Results showed that treatment of cultured anterior pituitary cells from adult male rats with inhibin (0-30 U/ml) for 72 h decreased Buserelin binding in a dose-dependent manner. In the presence of a maximally inhibiting dose of manner. In the presence of a maximally inhibiting dose of inhibin, Buserelin binding decreased progressively with time, reaching a minimum of 42% of the control value after 3 days. Exposure of pituitary cells for 3 days to the inhibin-related peptides transforming growth factor-beta (up to 400 pM) and Müllerian inhibitory substance (up to 100 nM) did not decrease binding of Buserelin, suggesting that the effect was specific to inhibin. Inhibin did not compete with iodinated Buserelin for GnRH-binding sites when they were added to the assay tube simultaneously. In addition, treatment with inhibin halved the number, but did not change the affinity, of GnRH-binding sites and had no effect on either cell number of cell viability. It is concluded that the reduction by inhibin of rat gonadotroph responsiveness to GnRH may be partly related to a decrease in the number of GnRH receptors on the cell surface.
Wang
Q F
QF
Medical Research Centre, Prince Henry's Hospital, Melbourne, Victoria, Australia.
Farnworth
P G
PG
Findlay
J K
JK
Burger
H G
HG
D000818:Animals; D054304:Anti-Mullerian Hormone; D001667:Binding, Competitive; D002064:Buserelin / Q000378:metabolism; D002452:Cell Count; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D006023:Glycoproteins; D007987:Gonadotropin-Releasing Hormone / Q000378:metabolism*; D006131:Growth Inhibitors; D007265:Inhibins / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D009095:Mullerian Ducts; D010903:Pituitary Gland, Anterior / Q000187:drug effects / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D011966:Receptors, LHRH / Q000187:drug effects / Q000378:metabolism; D013735:Testicular Hormones / Q000494:pharmacology; D015291:Transforming Growth Factors / Q000494:pharmacology
D006023:Glycoproteins; D006131:Growth Inhibitors; D011966:Receptors, LHRH; D013735:Testicular Hormones; D007987:Gonadotropin-Releasing Hormone; D007265:Inhibins; D015291:Transforming Growth Factors; D054304:Anti-Mullerian Hormone; D002064:Buserelin